Aquestive Therapeutics, Inc. — Form D

Aquestive Therapeutics, Inc. of WARREN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-09. The offering totals $9.1M, of which $9.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-05-09
• Form: D
• Accession: 0001398733-18-000003
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $9.1M
• Amount sold: $9.1M
• Minimum investment: $100
• Investors: 15
• Date of first sale: 2018-04-24
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-312010

Issuer

• Name: Aquestive Therapeutics, Inc.
• CIK: 0001398733
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 30 TECHNOLOGY DRIVE SOUTH, WARREN, NJ, 07059
• Phone: 908-941-1900

Officers, directors & promoters (13)

More

• CIK 1398733 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search